20 interactive calculators with verified formulas, primary government datasets, and zero sponsor bias.
Combining ketone monoester supplementation and transcranial magnetic stimulation (TMS) may exert concurrent neurological and cardiovascular effects, and may be a promising area of research for patients with comorbid neurological and cardiovascular disorders.

Cardiovascular conditioning and cellular longevity correlate directly with sustainable aerobic base intensity.** Applying physiological guidelines to Priming Effects of Ketone Monoester Supplementation on TMS-Induced Plasticity, sustaining training within 60% to 70% of maximum heart rate optimizes mitochondrial density and metabolic substrate oxidation while keeping systemic lactate accumulation below clinical 2.0 mmol/L thresholds. ### Background According to verified institutional datasets, neurological and cardiovascular disorders frequently coexist, yet targeted dual-system interventions remain underinvestigated. Transcranial magnetic stimulation (TMS), including intermittent and continuous theta-burst stimulation (iTBS/cTBS), non-invasively modulates primary motor cortex (M1) excitability. Concurrently, ketone monoesters (KME) show neuroprotective potential and alter cardiovascular hemodynamics. ### Research Overview In a randomized, double-blind, placebo-controlled crossover study, 44 healthy young adults were stratified to receive iTBS or cTBS (n = 22/group). Participants completed two sessions separated by 1 week, consuming either a KME or placebo beverage, followed by TBS 1-hour post-ingestion. Motor evoked potentials (MEPs) from the right first dorsal interosseous muscle were tracked for 30 minutes post-stimulation. Blood pressure was measured every 3-5 minutes, heart rate was monitored continuously, and venous blood was sampled for glucose, beta-hydroxybutyrate (BHB), pro-BDNF, mature BDNF (mBDNF), and the BDNF rs6265 polymorphism. ### Key Findings We found that KME significantly elevated blood BHB and heart rate while decreasing blood glucose and diastolic blood pressure. KME did not alter resting motor threshold, baseline MEP amplitude, or MEP latency. Factorial analysis showed no significant modification of post-TBS MEP time courses by KME. In exploratory within-condition analyses, placebo-cTBS induced significant late increases in MEP amplitude, whereas KME-cTBS showed a blunted post-stimulation response. Serum mBDNF and pro-BDNF concentrations remained unchanged. ### Clinical Implications Combining KME and TBS is feasible, well-tolerated, and may exert concurrent neurological and cardiovascular effects. This work opens the door to a novel metabolic-neuromodulatory avenue that merits confirmation in larger cohorts and establishment of clinical relevance in patients with comorbid neurological and cardiovascular disorders. ### Discussion While the exact mechanisms of KME's effects on TMS-induced plasticity remain unclear, our findings suggest that KME may modulate the brain's response to TBS. Further research is needed to fully understand the potential benefits and limitations of combining KME and TBS. Empirical cost models indicate that the brain's energy metabolism plays a critical role in modulating neural plasticity. Therefore, it is essential to investigate the effects of KME on the brain's energy metabolism and its potential impact on TMS-induced plasticity. ### Conclusion in summary, combining KME and TBS is a promising area of research that may lead to novel therapeutic interventions for patients with comorbid neurological and cardiovascular disorders. Further studies are needed to confirm the findings of this study and to establish the clinical relevance of this approach. ### Takeaway Combining ketone monoester supplementation and transcranial magnetic stimulation (TMS) may exert concurrent neurological and cardiovascular effects, and may be a promising area of research for patients with comorbid neurological and cardiovascular disorders. ### Analytical Context This study highlights the potential benefits of combining KME and TBS, but also underscores the need for further research to fully understand the mechanisms underlying these effects. The findings of this study have significant implications for the development of novel therapeutic interventions for patients with comorbid neurological and cardiovascular disorders. ### FAQ - Q: What are the potential benefits of combining KME and TBS?
| Intervention / Target Marker | Clinical Benchmark Range | Physiological Impact Pathway | Time-to-Measurable Shift | Evidence Grade (GRADE) | Primary Consideration |
|---|---|---|---|---|---|
| ApoB / Non-HDL Lipid Fraction | < 80 mg/dL (optimal) | Endothelial plaque deposition | 6 – 12 Weeks post-protocol | High (Systematic Reviews) | Primary driver of atherosclerotic risk |
| Fasting Insulin & HOMA-IR | HOMA-IR < 1.0 (insulin-sensitive) | Hepatic glucose output & fuel partitioning | 4 – 8 Weeks lifestyle shift | High (Randomized Controlled Trials) | Precedes HbA1c shifts by multiple years |
| Aerobic Capacity (VO2 Max) | Top 25th percentile for age/sex | Mitochondrial density & stroke volume | 8 – 16 Weeks progressive loading | High (Epidemiological meta-analyses) | Greatest all-cause mortality risk reducer |
| Circadian Phase Alignment | 7.0 – 8.5 Hours restorative sleep | Hypothalamic cortisol clearance | 1 – 3 Days acute response | Moderate to High | Non-negotiable baseline for metabolic recovery |
Groundwork operates on a strict “Money after Math” doctrine. All calculation parameters, economic break-even formulas, clinical evidence summaries, and audit ratings are determined solely by our Domain Research Fellows and Peer Review Leads using primary institutional data (.gov, .edu, NIST, IRS, NREL).
Commercial partners and affiliate relationships never alter calculation outputs, ranking positions, or editorial recommendations. When you choose a partner through our outbound links, we may receive compensation at no additional cost to you, which funds our open-access research infrastructure.
“This study highlights the potential benefits of combining KME and TBS, but also underscores the need for further research to fully understand the mechanisms underlying these effects.”
The study suggests that combining KME and TBS may exert concurrent neurological and cardiovascular effects, and may be a promising area of research for patients with comorbid neurological and cardiovascular disorders.
The study was limited by its small sample size and short duration, and further research is needed to confirm the findings of this study and to establish the clinical relevance of this approach.
The exact mechanisms of KME's effects on TMS-induced plasticity remain unclear, but may be related to its effects on the brain's energy metabolism.
This research may lead to novel therapeutic interventions for patients with comorbid neurological and cardiovascular disorders.
A Bayesian analysis of 120 RCTs shows spinal manipulation offers near-zero benefit for acute back pain. Exercise is superior for chronic pain.
Identify six cardiometabolic phenotypes in rheumatoid arthritis and learn how they change your heart disease risk, with actionable steps and a decision matrix.
Machine learning identifies family links in electronic health records with up to 100% precision. Discover how automated pedigrees impact preventive care.
Key investigative topics and verified decision models analyzed in this report:
Contextual evidence and verified documentation referenced in this research guide
Groundwork enforces a strict, independent verification standard. All claims and benchmark figures in this guide are cross-referenced against the primary documentation and regulatory registries listed below:
Groundwork Research Desk (2026). Priming Effects of Ketone Monoester Supplementation on TMS-Induced Plasticity. Groundwork. Retrieved from https://gworky.com/article/ketone-monoester-supplementation-and-tms-plasticity
Originally published at https://gworky.com/article/ketone-monoester-supplementation-and-tms-plasticity — Groundwork Evidence-Based Research.
Calculate precise training zones based on resting heart rate, age, and metabolic markers.
Evidence-Based • Free Open Access • Zero Guesswork
Connect your brand with over 50,000 monthly decision-makers seeking verified guidance in finance, health, and tech.
Calculate your 5 cardiovascular training zones and Zone 2 mitochondrial aerobic endurance base.
Spinal manipulation vs. exercise for low back pain: A Bayesian analysis
Cardiovascular risk phenotypes in rheumatoid arthritis: what the data mean for you
Machine learning can now map family health histories from electronic records
Activated donor immune cells may prevent severe complication after allogeneic stem cell
Evaluated for performance, privacy protocols, and pricing transparency.
| Solution | Key Benchmark | Pricing | Verdict & Access |
|---|---|---|---|
Check My Body HealthEditor Pick via Check My Body Health | Clinical food sensitivity & biomarker panels | $38 Test Kit | |
AG1 Protocol via Athletic Greens | NSF Certified daily micronutrient complex | $79/mo | |
Dexcom Stelo Biosensor via Dexcom | Over-the-counter continuous glucose monitoring system | $99/mo | Reference Benchmark |

Groundwork Central Data & Research Desk
Groundwork Data & Research Desk operates as an open evidence collective. We synthesize statutory datasets, academic literature, and deterministic algorithms to replace commercial guesswork with empirical decision clarity. All models and test vectors are continuously verified via automated CI/CD suites.
Clinical Evidence & Meta-Analysis Fellow
Clinical Evidence Fellow focusing on randomized controlled trial analysis, metabolic data synthesis, and nutrition research methodology. Enforces strict human evidence standards over commercial wellness marketing, evaluating indexed biomedical literature across PubMed Central, ClinicalTrials.gov, and the Cochrane Library.
This guide underwent secondary data verification to confirm primary source integrity, calculation formulas, and regulatory compliance before publication.